Floatz logo

14 assets in Acute Coronary Syndrome

Therapeutic assets addressing Acute Coronary Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Aspirin
Acute Coronary Syndrome
Shanghai CureGene Pharmaceutical Co., Ltd.P4BBB (75)
Atorvastatin
Acute Coronary Syndrome
Punjab Institute of CardologyP4BB (71)
Clopidogrel
Acute Coronary Syndrome
Shanghai CureGene Pharmaceutical Co., Ltd.P4BB (69)
Ticagrelor
Acute Coronary Syndrome
Tianjin Institute of Pharmaceutical Research Co., LtdP4BB (69)
Rosuvastatin
Acute Coronary Syndrome
Nanjing First Hospital, Nanjing Medical UniversityP4BB (67)
Bempedoic Acid
Acute Coronary Syndrome
Punjab Institute of CardologyP4BB (65)
Ezetimibe
Acute Coronary Syndrome
Punjab Institute of CardologyP4BB (65)
Ferric Cation
Acute Coronary Syndrome
Fundación para la Investigación del Hospital Clínico de ValenciaP4BB (65)
Inclisiran
Acute Coronary Syndrome
Novartis PharmaceuticalsP3B (60)
Dapagliflozin
Acute Coronary Syndrome
University of Sao PauloP2/3CCC (55)
Tiprogrel
Acute Coronary Syndrome
Tianjin Institute of Pharmaceutical Research Co., LtdP1CC (44)
cg-0255 besylate
Acute Coronary Syndrome
Shanghai CureGene Pharmaceutical Co., Ltd.P1CC (43)
cg-0255 besylate for
Acute Coronary Syndrome
Shanghai CureGene Pharmaceutical Co., Ltd.P1CC (43)
Isis-681257 (Galnac3--Conjugated Aso Targeting Human Lipoprotein (A) )
Acute Coronary Syndrome
University Medical Centre LjubljanaN/AD (30)